Leonard S. Schleifer - 31 Mar 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
President & CEO, Director
Signature
/s/**Leonard S. Schleifer
Issuer symbol
REGN
Transactions as of
31 Mar 2022
Net transactions value
-$2,049,089
Form type
4
Filing time
04 Apr 2022, 16:03:48 UTC
Previous filing
19 Nov 2021
Next filing
07 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale $2,049,089 -2,886 -14% $710.01 18,292 31 Mar 2022 By Trust F1, F2
holding REGN Common Stock 465,922 31 Mar 2022 Direct
holding REGN Common Stock 200,000 31 Mar 2022 2021 GRAT
holding REGN Common Stock 5,874 31 Mar 2022 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 Represents volume-weighted average price of sales of 2,886 shares of Company stock on March 31, 2022 at prices ranging from $710.00 to $710.10. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 31, 2022 at each separate price.